American Shared Hospital Services (NYSEAMERICAN:AMS) Coverage Initiated at StockNews.com

Equities research analysts at StockNews.com initiated coverage on shares of American Shared Hospital Services (NYSEAMERICAN:AMS) in a research note issued on Thursday. The firm set a “hold” rating on the stock.

American Shared Hospital Services Stock Performance

NYSEAMERICAN:AMS opened at $3.19 on Thursday. American Shared Hospital Services has a 52 week low of $2.16 and a 52 week high of $3.69. The company has a current ratio of 1.98, a quick ratio of 1.98 and a debt-to-equity ratio of 0.49. The firm has a market capitalization of $20.19 million, a price-to-earnings ratio of 39.88 and a beta of 0.70.

American Shared Hospital Services (NYSEAMERICAN:AMS) last posted its quarterly earnings data on Tuesday, May 14th. The company reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by ($0.01). The firm had revenue of $5.22 million during the quarter, compared to analysts’ expectations of $5.01 million. American Shared Hospital Services had a net margin of 2.50% and a return on equity of 4.29%. On average, equities research analysts anticipate that American Shared Hospital Services will post 0.29 EPS for the current fiscal year.

Institutional Investors Weigh In On American Shared Hospital Services

A hedge fund recently bought a new stake in American Shared Hospital Services stock. Empowered Funds LLC bought a new stake in American Shared Hospital Services (NYSEAMERICAN:AMS) in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 10,468 shares of the company’s stock, valued at approximately $31,000. Empowered Funds LLC owned 0.17% of American Shared Hospital Services as of its most recent SEC filing. Institutional investors and hedge funds own 23.16% of the company’s stock.

About American Shared Hospital Services

American Shared Hospital Services provides stereotactic radiosurgery and advanced radiation therapy equipment. It operates in two segments, Medical Equipment Leasing, and Retail. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia.